RYAH Group (CSE: RYAH) today announced its entry into a non-binding letter of intent (“LOI”) with Omni Services LLC (d/b/a “Omni Medical Services” or “Omni”), a leading physician-owned and operated telehealth, cannabis clinic and certifications company operating in the United States, with respect to the potential acquisition of 100% of the business and assets of Omni. The LOI, if consummated, is expected to combine Omni’s clinical research capabilities with the company’s IoT monitoring and control devices, and further the company’s ability to procure state and federal grants in the United States, which are reserved for the funding of clinical research studies focused on the advancement of plant medicine therapies. In particular, the transaction is expected to unite RYAH’s captive patient data platform with Omni’s approximately 20,000 U.S.-based medical cannabis patient network and tele-health solutions, to create a complete, closed-loop digital care ecosystem in plant-medicine therapies, from patient on-boarding, medicine administration, session monitoring and patient feedback. “Omni’s research expertise and network of certified physicians and patients will enable RYAH to develop new and innovative clinical studies, leveraging the ever-growing pool of funding designated for understanding the efficacy of plant-based therapies in the United States,” said RYAH CEO Gregory Wagner. “The complementary expertise that Omni and RYAH bring to the table is expected to accelerate our plans to be a U.S. and global market leader in the medical plant and nutraceutical intake industry, and generate significant value for our shareholders, partners, customers and patients.”
To view the full press release, visit https://ibn.fm/U4ZR1
About RYAH Group Inc.
RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates Health Insurance Portability and Accountability Act (“HIPAA”)-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. With a strong intellectual property portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle. For more information, visit www.RYAHGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
